Seeking Alpha

OXiGENE (OXGN) and the FDA reach a deal on a special protocol assessment for the Phase 3 trial...

OXiGENE (OXGN) and the FDA reach a deal on a special protocol assessment for the Phase 3 trial of its thyriod cancer drug zybrestat. Shares +14.8% AH.
Comments (2)
  • smokeyRose
    , contributor
    Comments (78) | Send Message
     
    I am with this stock!!!
    20 Sep 2012, 01:35 AM Reply Like
  • smokeyRose
    , contributor
    Comments (78) | Send Message
     
    I Bought this stock long ago for $2.00. the stock went up to $20.00!
    I Believe in this stock, at 66 cents ya can't go wrong!
    20 Sep 2012, 01:37 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs